Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
Clinical trial NCT04776655 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04776655
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2025-05-04
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.